Xhumana ne-Dermatitis ku-Cobalt
I-dermatitis yokuxhumana iyingozi, isikhukhula sesikhumba esikhanyayo ngokuvamile esibangelwa ukuthintana okuqondile kwento esikhumbeni. Kunezinhlobo ezimbili zoxhumo oxhumana naye: oluvuthayo kanye nokugula. Lo mkhuba ngokuvamile kunzima ukutshela ngokuhlukile futhi ngokuvamile akuyona into ebalulekile yokwenza. Ukuxhumana kwe-dermatitis kubangelwa ukuvakashelwa kwezidakamizwa ezigidini ezingu-5.7 ngonyaka e-United States, futhi bonke ubudala bayathinteka.
Amantombazane asetshenziselwa ukuthi abesilisa abathintekayo, kanti intsha kanye nabantu abadala asebekhulile kubonakala sengathi yiqembu elidlulele kakhulu elikhuthele.
Kuyini i-Vitamin B12?
I-Vitamin B12, ebizwa nangokuthi i-cobalamin, i-vithamini engenawo amanzi edlala indima ebalulekile ekwakheni amangqamuzana egazi nasemisebenzini evamile yesifo sezinzwa. I-cobalamin ivame ukutholakala emithonjeni yokudla, futhi amaningi amavithamini amaningi aqukethe inani elanele levithamini B12 impilo enhle.
I-Vitamin B12 Ukuntuleka
Ukwamukelwa kwamavithamini B12 kunzima kakhulu futhi kufaka izinyathelo ezihlukahlukene ezithintekayo, okungaholela ekutheni umthamo we-vitamin B12 ungasebenzi kahle emathunjini amancane. Ngenxa yalokho, ukutholakala kwevithamini B12 akuvamile, futhi abantu ababhekene nalesi simo bangadinga ukuthatha isisindo somlomo se-vitamin B12 noma ngomjovo. Abanye abantu bathatha amavithamini B12 amaningi, ikakhulukazi ngezinye izinhlobo zamavithamini B - okuthiwa i-vitamin B eyinkimbinkimbi - ngenhloso "yokuthuthukisa impilo".
Njengoba i-molecule ye-cobalamin iqukethe i-athomu ye-cobalt, ukuthatha amavithamini B12 amaningi (noma ngomlomo noma amafomu okujova) kungabangela ukuqhuma nokushaywa komuntu kubantu abanomlando we-cobalt. Nakuba lezi zimpendulo zingase zibe yingozi, zingabangela ukuqhuma okungahambi kahle.
Abantu abane-vitamin B12 kanye ne-cobalt yokungezwani komzimba kufanele-ke bathathe kuphela u-vitamin B12 ukuze balondoloze amazinga anele njengoba kulinganiswa nokuhlolwa kwegazi.
I-Cobalt Yokuzivocavoca Ithola Kanjani?
Ukuxilongwa kwe-cobalt yokungezwani komzimba kufanele kucatshangelwe uma umuntu othatha amavithamini B12 anezela noma yikuphi ukuqhuma okunamandla noma okungapheli okushayayo. I-rash ngokuvamile inamabhalane amancane aqukethe oketshezi ocacile, kodwa angavuvukala, akhuphuke, avule noma ahlasele kwezinye izimo. Ukuxilongwa kwenziwa nge-test patch, okubandakanya ukubekwa kwe-cobalt, namanye amakhemikhali, ngemuva ngemuva kwamahora angu-48 (akufani nokuhlolwa kobuchopho obunzima bokuzivikela). Lokhu ngokuvamile kwenziwa nge-paper tape system, njenge-test TRUE. Isivivinyo se-TRUE yiyona kuphela yokuhlolwa kwe-FDA evunyelwe ukuxhumana nodokotela e-United States, nakuba ezinye izifo eziphuthumayo nezidermatologists zizokwakha amaphaneli amaningi okuhlola ama-patch namakhemikhali athengwe eCanada noma eYurophu.
Imiphumela yokuhlolwa ihunyushwa emahoreni angu-48 ngemuva kokubekwa, futhi futhi emahoreni angu-72 noma angu-96 ngemuva kokubekwa.
Isivivinyo esiqinisekisiwe siqinisekiswa uma kunezibhansela, ubomvu nokuvuvukala okuncane esakhiweni samakhemikhali athile. Isayithi sovivinyo oluhle ngokuvamile luyizingqimba, nakuba ubukhulu bokuphendula buvame ukulinganiselwa kusayithi lokuxhumana, ngakho-ke kuvame ukuba luncane kune-dime.
Buka ukuthi ukuhlolwa kwe-patch kwenziwa kanjani .
I-Cobalt Ukuzivocavoca Kwenziwa Kanjani?
Ukuqhuma okuhambisana ne-cobalt yokungezwani komzimba / uxhumano lwe-dermatitis kungaphathwa nge -corticosteroids yama-topic noma i- corticosteroids ye-systemic (oral versus injectable). Kodwa-ke, ukwelashwa kwe-cobalt kungcono ukwelashwa ngokugwema amanani amaningi wevithamini B12. Abantu abanesifo se-vitamin B12 kufanele bathathe kuphela inani elincinci le-vitamin B12 elithathayo ukuze balondoloze amazinga ajwayelekile kavithamini B12 njengoba kulinganiswa nokuhlolwa kwegazi.
> Imithombo:
> Brescoll J, Daveluy S. Ukubuyekezwa kweVithamini B12 kuDermatology. Am J Clin Dermatol. 2015; 16: 27-33.
> Beltrani VS, Bernstein IL, Cohen DE, Fonacier L. Ukuxhumana ne-Dermatitis: I-Parameter Yokusebenza. Ann Ukuzivocavoca Isifo Somoya Immunol. 2006; > 97: S1-38 >.